INVERNIZZI PIETRO

Gatselis, N., Zachou, K., Loza, A., Cancado, E., Arinaga-Hino, T., Muratori, P., et al. (2023). Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 116(October 2023), 43-50 [10.1016/j.ejim.2023.06.001]. Detail

Kanai, M., Andrews, S., Cordioli, M., Stevens, C., Neale, B., Daly, M., et al. (2023). A second update on mapping the human genetic architecture of COVID-19. NATURE, 621(7977), 7-26 [10.1038/s41586-023-06355-3]. Detail

Hirschfield, G., Shiffman, M., Gulamhusein, A., Kowdley, K., Vierling, J., Levy, C., et al. (2023). Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. HEPATOLOGY, 78(2), 397-415 [10.1097/HEP.0000000000000395]. Detail

Murillo Perez, C., Gerussi, A., Trivedi, P., Corpechot, C., Van Der Meer, A., Maria Battezzati, P., et al. (2023). Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 35(1), 112-119 [10.1097/MEG.0000000000002464]. Detail

Cristoferi, L., Ciardullo, S., Invernizzi, P., Perseghin, G., Carbone, M. (2023). Endocrinology and Metabolic Diseases (Including Diabetes). In G.M. Hirschfield, P. Gill, J. Neuberger (a cura di), The Liver in Systemic Disease: A Clinician's Guide to Abnormal Liver Tests (pp. 99-109). Gideon M. Hirschfield, Paramjit Gill, James Neuberger [10.1002/9781119802181.ch8]. Detail